Back to search
Partial Seizures (With or Without Secondary Generalized Seizures)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Partial Seizures (With or Without Secondary Generalized Seizures) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Partial Seizures (With or Without Secondary Generalized Seizures) trials you may qualify forBackground : Psychiatric comorbidities are common in epilepsy, affecting 50 to 70% of patients, especially when the epilepsy is focal and drug-resistant. Among…
The primary purpose of this study is to assess the retention rate of perampanel as a reliable proxy for overall effectiveness and tolerability in participants a…
The objective of this study is to identify the following in adolescent epilepsy participants with partial-onset seizures (with or without secondary generalized…
The objective of this study is to identify the following in adult epilepsy participants with partial-onset seizures (with or without secondary generalized seizu…
The purpose of this study is to assess the safety of perampanel in the treatment of partial onset seizures in participants of age 12 years and older with epilep…
This is a multi-center, open-label, single-arm, phase 4 study to evaluate the efficacy of perampanel added to monotherapy for partial onset seizures with or wit…
The purpose of this study is to evaluate the safety and preliminary effectiveness of the novel compound RWJ-333369 in patients with partial onset seizures who a…
The purpose of this study is to assess a possible predictor for weight loss seen in epilepsy patients treated with topiramate.